Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib in non-HPV locally advanced head and neck cancer
NCT01711658Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- Mar 2013
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of lapatinib in head and neck cancer (HNC), sponsored by NRG Oncology. Started Mar 2013; status: completed.
02
Drugs
lapatinib
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT01711658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01711658.